State Board of Administration of Florida Retirement System Lowers Position in Cryoport, Inc. (NASDAQ:CYRX)

State Board of Administration of Florida Retirement System cut its holdings in shares of Cryoport, Inc. (NASDAQ:CYRX – Get Rating) by 4.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,638 shares of the consumer goods maker’s stock after selling 650 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Cryoport were worth $271,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of Cryoport by 4.7% during the 1st quarter. Vanguard Group Inc. now owns 3,515,305 shares of the consumer goods maker’s stock worth $122,720,000 after purchasing an additional 159,133 shares during the period. Invesco Ltd. grew its holdings in shares of Cryoport by 17.7% during the 1st quarter. Invesco Ltd. now owns 3,228,313 shares of the consumer goods maker’s stock worth $112,700,000 after purchasing an additional 485,972 shares during the period. BlackRock Inc. boosted its holdings in Cryoport by 2.0% during the 1st quarter. BlackRock Inc. now owns 3,028,269 shares of the consumer goods maker’s stock valued at $105,718,000 after acquiring an additional 59,877 shares during the period. Impax Asset Management Group plc boosted its holdings in Cryoport by 7.6% during the 3rd quarter. Impax Asset Management Group plc now owns 1,693,623 shares of the consumer goods maker’s stock valued at $40,988,000 after acquiring an additional 119,372 shares during the period. Finally, Chevy Chase Trust Holdings LLC boosted its holdings in Cryoport by 7.6% during the 3rd quarter. Chevy Chase Trust Holdings LLC now owns 1,678,740 shares of the consumer goods maker’s stock valued at $40,895,000 after acquiring an additional 119,250 shares during the period. 88.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Needham & Company LLC restated a “buy” rating and set a $30.00 target price on shares of Cryoport in a report on Friday, April 21st.

Insider Buying and Selling

In other Cryoport news, Director Richard J. Berman sold 7,203 shares of Cryoport stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $21.51, for a total value of $154,936.53. Following the transaction, the director now directly owns 100,000 shares in the company, valued at approximately $2,151,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Jerrell Shelton sold 141,159 shares of Cryoport stock in a transaction that occurred on Wednesday, May 10th. The stock was sold at an average price of $21.63, for a total value of $3,053,269.17. Following the sale, the chief executive officer now directly owns 605,299 shares in the company, valued at $13,092,617.37. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Richard J. Berman sold 7,203 shares of Cryoport stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $21.51, for a total value of $154,936.53. Following the completion of the sale, the director now owns 100,000 shares in the company, valued at $2,151,000. The disclosure for this sale can be found here. Insiders have sold 179,743 shares of company stock worth $3,879,341 in the last quarter. 10.50% of the stock is owned by insiders.

Cryoport Price Performance

CYRX stock opened at $20.15 on Monday. The company has a debt-to-equity ratio of 0.76, a current ratio of 14.54 and a quick ratio of 13.90. Cryoport, Inc. has a 1 year low of $15.63 and a 1 year high of $45.36. The firm has a market capitalization of $917.63 million, a P/E ratio of -25.83 and a beta of 1.32. The business’s 50-day moving average is $21.41 and its two-hundred day moving average is $20.53.

Cryoport (NASDAQ:CYRX – Get Rating) last issued its earnings results on Thursday, May 4th. The consumer goods maker reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02. Cryoport had a negative return on equity of 4.90% and a negative net margin of 11.91%. The business had revenue of $62.82 million for the quarter, compared to analyst estimates of $62.15 million. During the same quarter last year, the company earned ($0.31) EPS. The business’s quarterly revenue was up 20.1% on a year-over-year basis. Analysts anticipate that Cryoport, Inc. will post -0.64 earnings per share for the current fiscal year.

Cryoport Profile

(Get Rating)

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.